 | • レポートコード：MRC2-11QY04833 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はテネクテプラーゼ薬のグローバル市場について調査・分析したレポートです。種類別（静脈内投与量、血管内カテーテル点滴投与量）市場規模、用途別（病院、診療所、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別テネクテプラーゼ薬の競争状況、市場シェア ・世界のテネクテプラーゼ薬市場：種類別市場規模 2015年-2020年（静脈内投与量、血管内カテーテル点滴投与量） ・世界のテネクテプラーゼ薬市場：種類別市場規模予測 2021年-2026年（静脈内投与量、血管内カテーテル点滴投与量） ・世界のテネクテプラーゼ薬市場：用途別市場規模 2015年-2020年（病院、診療所、外来外科センター、その他） ・世界のテネクテプラーゼ薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、外来外科センター、その他） ・北米のテネクテプラーゼ薬市場分析：米国、カナダ ・ヨーロッパのテネクテプラーゼ薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのテネクテプラーゼ薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のテネクテプラーゼ薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのテネクテプラーゼ薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Boehringer Ingelheim、Genentech、Emcure Pharmaceuticals、Rewine pharmaceuticals、Hisun ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug.
It is estimated that North America dominated the global tenecteplase drug market owing to the increasing innovations in clinical practice, myocardial infection, and access to stroke treatment in this region.
Market Analysis and Insights: Global Tenecteplase Drugs Market
The global Tenecteplase Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tenecteplase Drugs Scope and Market Size
Tenecteplase Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tenecteplase Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Boehringer Ingelheim
Genentech
Emcure Pharmaceuticals
Rewine pharmaceuticals
Hisun
…
Market segment by Type, the product can be split into
Intravenous Dosage
Intracatheter Instillation Dosage
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tenecteplase Drugs Revenue
1.4 Market by Type
1.4.1 Global Tenecteplase Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intravenous Dosage
1.4.3 Intracatheter Instillation Dosage
1.5 Market by Application
1.5.1 Global Tenecteplase Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tenecteplase Drugs Market Perspective (2015-2026)
2.2 Global Tenecteplase Drugs Growth Trends by Regions
2.2.1 Tenecteplase Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tenecteplase Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Tenecteplase Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tenecteplase Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Tenecteplase Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tenecteplase Drugs Players by Market Size
3.1.1 Global Top Tenecteplase Drugs Players by Revenue (2015-2020)
3.1.2 Global Tenecteplase Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Tenecteplase Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tenecteplase Drugs Market Concentration Ratio
3.2.1 Global Tenecteplase Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tenecteplase Drugs Revenue in 2019
3.3 Tenecteplase Drugs Key Players Head office and Area Served
3.4 Key Players Tenecteplase Drugs Product Solution and Service
3.5 Date of Enter into Tenecteplase Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tenecteplase Drugs Historic Market Size by Type (2015-2020)
4.2 Global Tenecteplase Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tenecteplase Drugs Market Size by Application (2015-2020)
5.2 Global Tenecteplase Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tenecteplase Drugs Market Size (2015-2020)
6.2 Tenecteplase Drugs Key Players in North America (2019-2020)
6.3 North America Tenecteplase Drugs Market Size by Type (2015-2020)
6.4 North America Tenecteplase Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tenecteplase Drugs Market Size (2015-2020)
7.2 Tenecteplase Drugs Key Players in Europe (2019-2020)
7.3 Europe Tenecteplase Drugs Market Size by Type (2015-2020)
7.4 Europe Tenecteplase Drugs Market Size by Application (2015-2020)
8 China
8.1 China Tenecteplase Drugs Market Size (2015-2020)
8.2 Tenecteplase Drugs Key Players in China (2019-2020)
8.3 China Tenecteplase Drugs Market Size by Type (2015-2020)
8.4 China Tenecteplase Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tenecteplase Drugs Market Size (2015-2020)
9.2 Tenecteplase Drugs Key Players in Japan (2019-2020)
9.3 Japan Tenecteplase Drugs Market Size by Type (2015-2020)
9.4 Japan Tenecteplase Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tenecteplase Drugs Market Size (2015-2020)
10.2 Tenecteplase Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tenecteplase Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Tenecteplase Drugs Market Size by Application (2015-2020)
11 India
11.1 India Tenecteplase Drugs Market Size (2015-2020)
11.2 Tenecteplase Drugs Key Players in India (2019-2020)
11.3 India Tenecteplase Drugs Market Size by Type (2015-2020)
11.4 India Tenecteplase Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tenecteplase Drugs Market Size (2015-2020)
12.2 Tenecteplase Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Tenecteplase Drugs Market Size by Type (2015-2020)
12.4 Central & South America Tenecteplase Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Tenecteplase Drugs Introduction
13.1.4 Merck Revenue in Tenecteplase Drugs Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Tenecteplase Drugs Introduction
13.2.4 Boehringer Ingelheim Revenue in Tenecteplase Drugs Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 Genentech
13.3.1 Genentech Company Details
13.3.2 Genentech Business Overview
13.3.3 Genentech Tenecteplase Drugs Introduction
13.3.4 Genentech Revenue in Tenecteplase Drugs Business (2015-2020)
13.3.5 Genentech Recent Development
13.4 Emcure Pharmaceuticals
13.4.1 Emcure Pharmaceuticals Company Details
13.4.2 Emcure Pharmaceuticals Business Overview
13.4.3 Emcure Pharmaceuticals Tenecteplase Drugs Introduction
13.4.4 Emcure Pharmaceuticals Revenue in Tenecteplase Drugs Business (2015-2020)
13.4.5 Emcure Pharmaceuticals Recent Development
13.5 Rewine pharmaceuticals
13.5.1 Rewine pharmaceuticals Company Details
13.5.2 Rewine pharmaceuticals Business Overview
13.5.3 Rewine pharmaceuticals Tenecteplase Drugs Introduction
13.5.4 Rewine pharmaceuticals Revenue in Tenecteplase Drugs Business (2015-2020)
13.5.5 Rewine pharmaceuticals Recent Development
13.6 Hisun
13.6.1 Hisun Company Details
13.6.2 Hisun Business Overview
13.6.3 Hisun Tenecteplase Drugs Introduction
13.6.4 Hisun Revenue in Tenecteplase Drugs Business (2015-2020)
13.6.5 Hisun Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tenecteplase Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Tenecteplase Drugs Revenue
Table 3. Ranking of Global Top Tenecteplase Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tenecteplase Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous Dosage
Table 6. Key Players of Intracatheter Instillation Dosage
Table 7. Global Tenecteplase Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Tenecteplase Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Tenecteplase Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Tenecteplase Drugs Market Share by Regions (2015-2020)
Table 11. Global Tenecteplase Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Tenecteplase Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Tenecteplase Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Tenecteplase Drugs Players
Table 18. Global Tenecteplase Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Tenecteplase Drugs Market Share by Players (2015-2020)
Table 20. Global Top Tenecteplase Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tenecteplase Drugs as of 2019)
Table 21. Global Tenecteplase Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tenecteplase Drugs Product Solution and Service
Table 24. Date of Enter into Tenecteplase Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Tenecteplase Drugs Market Size Share by Type (2015-2020)
Table 28. Global Tenecteplase Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Tenecteplase Drugs Market Size Share by Application (2015-2020)
Table 30. Global Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Tenecteplase Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 34. North America Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Tenecteplase Drugs Market Share by Type (2015-2020)
Table 36. North America Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Tenecteplase Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 40. Europe Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Tenecteplase Drugs Market Share by Type (2015-2020)
Table 42. Europe Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Tenecteplase Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 46. China Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Tenecteplase Drugs Market Share by Type (2015-2020)
Table 48. China Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Tenecteplase Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 52. Japan Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Tenecteplase Drugs Market Share by Type (2015-2020)
Table 54. Japan Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Tenecteplase Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 58. Southeast Asia Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Tenecteplase Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Tenecteplase Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 64. India Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Tenecteplase Drugs Market Share by Type (2015-2020)
Table 66. India Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Tenecteplase Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Tenecteplase Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Tenecteplase Drugs Market Share (2019-2020)
Table 70. Central & South America Tenecteplase Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Tenecteplase Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Tenecteplase Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Tenecteplase Drugs Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Product
Table 82. Boehringer Ingelheim Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 83. Boehringer Ingelheim Recent Development
Table 84. Genentech Company Details
Table 85. Genentech Business Overview
Table 86. Genentech Product
Table 87. Genentech Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 88. Genentech Recent Development
Table 89. Emcure Pharmaceuticals Company Details
Table 90. Emcure Pharmaceuticals Business Overview
Table 91. Emcure Pharmaceuticals Product
Table 92. Emcure Pharmaceuticals Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 93. Emcure Pharmaceuticals Recent Development
Table 94. Rewine pharmaceuticals Company Details
Table 95. Rewine pharmaceuticals Business Overview
Table 96. Rewine pharmaceuticals Product
Table 97. Rewine pharmaceuticals Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 98. Rewine pharmaceuticals Recent Development
Table 99. Hisun Company Details
Table 100. Hisun Business Overview
Table 101. Hisun Product
Table 102. Hisun Revenue in Tenecteplase Drugs Business (2015-2020) (Million US$)
Table 103. Hisun Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tenecteplase Drugs Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Dosage Features
Figure 3. Intracatheter Instillation Dosage Features
Figure 4. Global Tenecteplase Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Tenecteplase Drugs Report Years Considered
Figure 10. Global Tenecteplase Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Tenecteplase Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Tenecteplase Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Tenecteplase Drugs Market Share by Players in 2019
Figure 15. Global Top Tenecteplase Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tenecteplase Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Tenecteplase Drugs Revenue in 2019
Figure 17. North America Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Tenecteplase Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…- 静脈内鉄薬の世界市場（～2026年） Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of …
- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- チロシンヒドロキシラーゼ欠損症治療薬の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…